| Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets B Rocca, P Secchiero, G Ciabattoni, FO Ranelletti, L Catani, L Guidotti, ... Proceedings of the National Academy of Sciences 99 (11), 7634-7639, 2002 | 441 | 2002 |
| A novel model of CCl4-induced cirrhosis with ascites in the mouse M Domenicali, P Caraceni, F Giannone, M Baldassarre, G Lucchetti, ... Journal of hepatology 51 (6), 991-999, 2009 | 185 | 2009 |
| Acute-and chronic-phase chronic myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of c-myb antisense oligodeoxynucleotides MZ Ratajczak, N Hijiya, L Catani, K DeRiel, SM Luger, P McGlave, ... Blood 79 (8), 1956-1961, 1992 | 139 | 1992 |
| Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor RM Lemoli, A Tafuri, A Fortuna, MT Petrucci, MR Ricciardi, L Catani, ... Blood 89 (4), 1189-1196, 1997 | 131 | 1997 |
| Mobilization of bone marrow‐derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection RM Lemoli, L Catani, S Talarico, E Loggi, A Gramenzi, U Baccarani, ... Stem Cells 24 (12), 2817-2825, 2006 | 127 | 2006 |
| Dendritic cells of immune thrombocytopenic purpura (ITP) show increased capacity to present apoptotic platelets to T lymphocytes L Catani, ME Fagioli, PL Tazzari, F Ricci, A Curti, M Rovito, P Preda, ... Experimental hematology 34 (7), 879-887, 2006 | 120 | 2006 |
| Long-term follow-up of idiopathic thrombocytopenic purpura in 310 patients N Vianelli, L Valdrè, M Fiacchini, A De Vivo, L Gugliotta, L Catani, ... haematologica 86 (5), 504-509, 2001 | 114 | 2001 |
| Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years F Palandri, N Polverelli, D Sollazzo, M Romano, L Catani, M Cavo, ... American journal of hematology 91 (4), E267-E272, 2016 | 102 | 2016 |
| Cancer procoagulant in acute non lymphoid leukemia: relationship of enzyme detection to disease activity MB Donati, A Falanga, R Consonni, MG Alessio, R Bassan, M Buelli, ... Thrombosis and haemostasis 64 (01), 011-016, 1990 | 94 | 1990 |
| Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis F Palandri, R Latagliata, N Polverelli, A Tieghi, M Crugnola, B Martino, ... Leukemia 29 (6), 1344, 2015 | 91 | 2015 |
| Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells E Tenedini, ME Fagioli, N Vianelli, PL Tazzari, F Ricci, E Tagliafico, ... Blood 104 (10), 3126-3135, 2004 | 88 | 2004 |
| Long‐term follow‐up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy F Palandri, L Catani, N Testoni, E Ottaviani, N Polverelli, M Fiacchini, ... American journal of hematology 84 (4), 215-220, 2009 | 82 | 2009 |
| Impact of leukocytosis on thrombotic risk and survival in 532 patients with essential thrombocythemia: a retrospective study F Palandri, N Polverelli, L Catani, E Ottaviani, M Baccarani, N Vianelli Annals of hematology 90 (8), 933-938, 2011 | 80 | 2011 |
| Hypercoagulability during l‐asparaginase treatment: the effect of antithrombin III supplementation in vivo L Gugliotta, A D'Angelo, MM Belmonte, S Viganò‐D'Angelo, G Colombo, ... British journal of haematology 74 (4), 465-470, 1990 | 79 | 1990 |
| In vivo and in vitro inhibitory effect of α‐interferon on megakaryocyte colony growth in essential thrombocythaemia L Gugliotta, GP Bagnara, L Catani, L Gaggioli, A Guarini, G Zauli, ... British journal of haematology 71 (2), 177-181, 1989 | 79 | 1989 |
| Baseline factors associated with response to ruxolitinib: an independent study on 408 patients with myelofibrosis F Palandri, GA Palumbo, M Bonifacio, M Tiribelli, G Benevolo, B Martino, ... Oncotarget 8 (45), 79073, 2017 | 76 | 2017 |
| Stem cell mobilization and collection in patients with liver cirrhosis S Lorenzini, A Isidori, L Catani, A Gramenzi, S Talarico, F Bonifazi, ... Alimentary pharmacology & therapeutics 27 (10), 932-939, 2008 | 76 | 2008 |
| Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients N Polverelli, M Breccia, G Benevolo, B Martino, A Tieghi, R Latagliata, ... American journal of hematology 92 (1), 37-41, 2017 | 74 | 2017 |
| Decreased expression of indoleamine 2, 3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia L Catani, D Sollazzo, S Trabanelli, A Curti, C Evangelisti, N Polverelli, ... Annals of hematology 92 (1), 67-78, 2013 | 74 | 2013 |
| Identification of Gz alpha as a pertussis toxin-insensitive G protein in human platelets and megakaryocytes AW Gagnon, DR Manning, L Catani, A Gewirtz, M Poncz, LF Brass Blood 78 (5), 1247-1253, 1991 | 68 | 1991 |
